BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
T cell receptor signaling pathway
,
Ischemia
,
Hippocampus
,
Alcohol
,
Valproic acid
,
MYC
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Anoctamin
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Tonsil
Tongue main corpus
Caudate
Putamen
Ovary
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Placental insufficiency
Pyloric ulcer
Dehydration
Immunoglobulin G4 deficiency
Viral carditis
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
CP 724714
PD 184352
Carbonyl Cyanide m-Chlorophenyl Hydrazone
A-66
CGP 60474
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
il4r
ITCH
CACTIN
NOP2
NKX2-3
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Dicer1 knockout gene expression during Schwann cell development
Pheochromocytoma and paraganglioma miRNA profiles
L1000 CMAP - Neuronal NEU cells treated with small molecule perturbagens
Hemin treatment, GATA1, EKLF or NF-E2 over-expressing and knocking-down in K562 cells
Tumorigenic and non-tumorigenic African green monkey kidney cell miRNA expression
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for Anoctamin
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
MRI-phenotyping of Patients With Pathogenic Anoctamin 5 Variants
3 Year Follow up on ANO5 Patients
SSG XXV: The Stop-GIST Trial; Discontinuation of Imatinib in Patients With Oligo-metastatic GIST
Congenital Muscle Disease Study of Patient and Family Reported Medical Information
β-cell Function and Insulin Sensitivity in Patients With Cystic Fibrosis
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ